TGFB2 and colorectal carcinoma: In our study, this CRC subgroup displaying this trend toward a higher frequency of BRAF mutations (21.7%) and TGFB2 mutations (12.5%) consisted of predominantly right‐sided CRC cases (50%) and exhibited a higher risk of recurrent peritoneal seeding (12.5%).